CJMB
CJMB
CALLAN JMB INC.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.45M ▼ | $2.37M ▲ | $-2.73M ▼ | -188.77% ▼ | $-0.61 ▼ | $-2.69M ▼ |
| Q2-2025 | $1.67M ▲ | $2.05M ▲ | $-1.4M ▼ | -83.87% ▲ | $-0.31 ▲ | $-1.36M ▼ |
| Q1-2025 | $1.45M ▲ | $1.85M ▲ | $-1.24M ▲ | -85.59% ▲ | $-0.32 ▲ | $-1.2M ▲ |
| Q4-2024 | $1.35M ▼ | $1.69M ▲ | $-1.3M ▼ | -95.81% ▼ | $-0.43 ▼ | $-1.23M ▼ |
| Q3-2024 | $1.44M | $1.25M | $-804.99K | -56.08% | $-0.27 | $-745.35K |
What's going well?
Non-operating income provided a small cushion against even bigger losses. Interest costs are low, so debt isn't a major problem. No big one-time charges distorted results.
What's concerning?
Revenue dropped sharply, losses nearly doubled, and operating expenses are rising much faster than sales. The company is losing money at a faster rate, and no investment in R&D or sales could hurt future growth.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $2.79M ▼ | $7.74M ▼ | $3.56M ▲ | $4.18M ▼ |
| Q2-2025 | $4.22M ▼ | $8.97M ▲ | $3.14M ▲ | $5.83M ▼ |
| Q1-2025 | $5.22M ▲ | $8.46M ▲ | $1.65M ▼ | $6.81M ▲ |
| Q4-2024 | $2.1M ▼ | $5.08M ▼ | $1.91M ▼ | $3.17M ▼ |
| Q3-2024 | $2.81M | $6.38M | $1.97M | $4.41M |
What's financially strong about this company?
They have no goodwill or intangibles, so assets are high quality and tangible. The company is very liquid, with plenty of current assets to cover near-term bills. Debt is moderate and mostly long-term.
What are the financial risks or weaknesses?
Cash fell by a third in just one quarter, and equity dropped sharply. Receivables and inventory are rising, which could mean cash is getting tied up and customers are paying slower. The company has a long history of losses.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-2.73M ▼ | $-1.76M ▼ | $-169.39K ▲ | $497.75K ▲ | $-1.43M ▼ | $-1.93M ▼ |
| Q2-2025 | $-1.4M ▼ | $-563.27K ▲ | $-432.51K ▼ | $0 ▼ | $-995.78K ▼ | $-995.78K ▲ |
| Q1-2025 | $-1.24M ▲ | $-1.56M ▼ | $-15K ▼ | $4.7M ▲ | $3.12M ▲ | $-1.58M ▼ |
| Q4-2024 | $-1.3M ▼ | $-723.17K ▼ | $0 ▲ | $11.81K ▲ | $-711.36K ▼ | $-723.17K ▼ |
| Q3-2024 | $-804.99K | $988K | $-293 | $-26.13K | $961.58K | $987.71K |
What's strong about this company's cash flow?
The company still has nearly $2.8 million in cash left and reduced capital spending this quarter. No new debt or dilution means existing shareholders aren't being diluted yet.
What are the cash flow concerns?
Cash burn more than doubled, and losses are mostly real cash out the door. At this pace, cash could run out in a couple of quarters unless things turn around or new funding is raised.
5-Year Trend Analysis
A comprehensive look at CALLAN JMB INC.'s financial evolution and strategic trajectory over the past five years.
CJMB’s core strengths lie in its specialization and capabilities rather than in its current financial performance. It occupies a valuable niche in temperature‑sensitive and regulated logistics, underpinned by proprietary technology, deep regulatory expertise, and long‑standing relationships with government and healthcare clients. Historically, the business has demonstrated the ability to generate strong margins and robust cash flow, and the current debt load remains relatively low. Its pipeline of initiatives—particularly in GLP‑1 logistics, CDMO services, international expansion, and strategic partnerships—offers multiple avenues for potential growth if executed well.
On the risk side, the company faces a combination of sharp operational and financial headwinds. Revenue has declined drastically, profitability has flipped to losses, and cash generation has weakened to the point where dividends exceed free cash flow. The balance sheet, while not over‑levered, is deteriorating, with shrinking cash reserves, lower equity, and reduced liquidity buffers. Competitive and contract risks appear elevated in light of the revenue drop, and ambitious growth plans will require capital at a time when internal funding capacity is limited. Together, these factors create meaningful uncertainty around the company’s ability to stabilize and scale its business without further strain on its financial position.
The outlook for CJMB is mixed and highly execution‑dependent. On one hand, it operates in structurally attractive markets with growing demand for cold‑chain and high‑compliance logistics, and it has distinctive tools and expertise that can address those needs. On the other hand, the recent collapse in revenue and profitability, coupled with weaker liquidity and underinvestment in assets, suggests that the near‑term focus will need to be on stabilization: regaining volume, aligning costs with the new scale of the business, and rebalancing capital allocation. If the company can secure and ramp its new partnerships and initiatives while restoring cash generation, the longer‑term potential remains significant; if not, financial constraints could limit its ability to fully capitalize on its strategic positioning.
About CALLAN JMB INC.
https://www.coldchain-tech.comCallan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.45M ▼ | $2.37M ▲ | $-2.73M ▼ | -188.77% ▼ | $-0.61 ▼ | $-2.69M ▼ |
| Q2-2025 | $1.67M ▲ | $2.05M ▲ | $-1.4M ▼ | -83.87% ▲ | $-0.31 ▲ | $-1.36M ▼ |
| Q1-2025 | $1.45M ▲ | $1.85M ▲ | $-1.24M ▲ | -85.59% ▲ | $-0.32 ▲ | $-1.2M ▲ |
| Q4-2024 | $1.35M ▼ | $1.69M ▲ | $-1.3M ▼ | -95.81% ▼ | $-0.43 ▼ | $-1.23M ▼ |
| Q3-2024 | $1.44M | $1.25M | $-804.99K | -56.08% | $-0.27 | $-745.35K |
What's going well?
Non-operating income provided a small cushion against even bigger losses. Interest costs are low, so debt isn't a major problem. No big one-time charges distorted results.
What's concerning?
Revenue dropped sharply, losses nearly doubled, and operating expenses are rising much faster than sales. The company is losing money at a faster rate, and no investment in R&D or sales could hurt future growth.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $2.79M ▼ | $7.74M ▼ | $3.56M ▲ | $4.18M ▼ |
| Q2-2025 | $4.22M ▼ | $8.97M ▲ | $3.14M ▲ | $5.83M ▼ |
| Q1-2025 | $5.22M ▲ | $8.46M ▲ | $1.65M ▼ | $6.81M ▲ |
| Q4-2024 | $2.1M ▼ | $5.08M ▼ | $1.91M ▼ | $3.17M ▼ |
| Q3-2024 | $2.81M | $6.38M | $1.97M | $4.41M |
What's financially strong about this company?
They have no goodwill or intangibles, so assets are high quality and tangible. The company is very liquid, with plenty of current assets to cover near-term bills. Debt is moderate and mostly long-term.
What are the financial risks or weaknesses?
Cash fell by a third in just one quarter, and equity dropped sharply. Receivables and inventory are rising, which could mean cash is getting tied up and customers are paying slower. The company has a long history of losses.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-2.73M ▼ | $-1.76M ▼ | $-169.39K ▲ | $497.75K ▲ | $-1.43M ▼ | $-1.93M ▼ |
| Q2-2025 | $-1.4M ▼ | $-563.27K ▲ | $-432.51K ▼ | $0 ▼ | $-995.78K ▼ | $-995.78K ▲ |
| Q1-2025 | $-1.24M ▲ | $-1.56M ▼ | $-15K ▼ | $4.7M ▲ | $3.12M ▲ | $-1.58M ▼ |
| Q4-2024 | $-1.3M ▼ | $-723.17K ▼ | $0 ▲ | $11.81K ▲ | $-711.36K ▼ | $-723.17K ▼ |
| Q3-2024 | $-804.99K | $988K | $-293 | $-26.13K | $961.58K | $987.71K |
What's strong about this company's cash flow?
The company still has nearly $2.8 million in cash left and reduced capital spending this quarter. No new debt or dilution means existing shareholders aren't being diluted yet.
What are the cash flow concerns?
Cash burn more than doubled, and losses are mostly real cash out the door. At this pace, cash could run out in a couple of quarters unless things turn around or new funding is raised.
5-Year Trend Analysis
A comprehensive look at CALLAN JMB INC.'s financial evolution and strategic trajectory over the past five years.
CJMB’s core strengths lie in its specialization and capabilities rather than in its current financial performance. It occupies a valuable niche in temperature‑sensitive and regulated logistics, underpinned by proprietary technology, deep regulatory expertise, and long‑standing relationships with government and healthcare clients. Historically, the business has demonstrated the ability to generate strong margins and robust cash flow, and the current debt load remains relatively low. Its pipeline of initiatives—particularly in GLP‑1 logistics, CDMO services, international expansion, and strategic partnerships—offers multiple avenues for potential growth if executed well.
On the risk side, the company faces a combination of sharp operational and financial headwinds. Revenue has declined drastically, profitability has flipped to losses, and cash generation has weakened to the point where dividends exceed free cash flow. The balance sheet, while not over‑levered, is deteriorating, with shrinking cash reserves, lower equity, and reduced liquidity buffers. Competitive and contract risks appear elevated in light of the revenue drop, and ambitious growth plans will require capital at a time when internal funding capacity is limited. Together, these factors create meaningful uncertainty around the company’s ability to stabilize and scale its business without further strain on its financial position.
The outlook for CJMB is mixed and highly execution‑dependent. On one hand, it operates in structurally attractive markets with growing demand for cold‑chain and high‑compliance logistics, and it has distinctive tools and expertise that can address those needs. On the other hand, the recent collapse in revenue and profitability, coupled with weaker liquidity and underinvestment in assets, suggests that the near‑term focus will need to be on stabilization: regaining volume, aligning costs with the new scale of the business, and rebalancing capital allocation. If the company can secure and ramp its new partnerships and initiatives while restoring cash generation, the longer‑term potential remains significant; if not, financial constraints could limit its ability to fully capitalize on its strategic positioning.

CEO
Wayne Williams
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C

